125 related articles for article (PubMed ID: 38158037)
1. Purification and characterization of Cdr1, the drug-efflux pump conferring azole resistance in Candida species.
Pata J; Moreno A; Wiseman B; Magnard S; Lehlali I; Dujardin M; Banerjee A; Högbom M; Boumendjel A; Chaptal V; Prasad R; Falson P
Biochimie; 2024 May; 220():167-178. PubMed ID: 38158037
[TBL] [Abstract][Full Text] [Related]
2. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
3. Relative Contribution of the ABC Transporters Cdr1, Pdh1, and Snq2 to Azole Resistance in Candida glabrata.
Whaley SG; Zhang Q; Caudle KE; Rogers PD
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30038038
[TBL] [Abstract][Full Text] [Related]
4. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
Sanglard D; Coste AT
Antimicrob Agents Chemother; 2016 Jan; 60(1):229-38. PubMed ID: 26482310
[TBL] [Abstract][Full Text] [Related]
5. The monoamine oxidase A inhibitor clorgyline is a broad-spectrum inhibitor of fungal ABC and MFS transporter efflux pump activities which reverses the azole resistance of Candida albicans and Candida glabrata clinical isolates.
Holmes AR; Keniya MV; Ivnitski-Steele I; Monk BC; Lamping E; Sklar LA; Cannon RD
Antimicrob Agents Chemother; 2012 Mar; 56(3):1508-15. PubMed ID: 22203607
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters.
Sanglard D; Kuchler K; Ischer F; Pagani JL; Monod M; Bille J
Antimicrob Agents Chemother; 1995 Nov; 39(11):2378-86. PubMed ID: 8585712
[TBL] [Abstract][Full Text] [Related]
7. Milbemycins: more than efflux inhibitors for fungal pathogens.
Silva LV; Sanguinetti M; Vandeputte P; Torelli R; Rochat B; Sanglard D
Antimicrob Agents Chemother; 2013 Feb; 57(2):873-86. PubMed ID: 23208712
[TBL] [Abstract][Full Text] [Related]
8. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
Maurya IK; Thota CK; Verma SD; Sharma J; Rawal MK; Ravikumar B; Sen S; Chauhan N; Lynn AM; Chauhan VS; Prasad R
J Biol Chem; 2013 Jun; 288(23):16775-16787. PubMed ID: 23592791
[TBL] [Abstract][Full Text] [Related]
9. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the heterologous bias: an in vivo functional analysis of multidrug efflux transporter, CgCdr1p in matched pair clinical isolates of Candida glabrata.
Puri N; Manoharlal R; Sharma M; Sanglard D; Prasad R
Biochem Biophys Res Commun; 2011 Jan; 404(1):357-63. PubMed ID: 21134356
[TBL] [Abstract][Full Text] [Related]
11. Expression of the CDR1 efflux pump in clinical Candida albicans isolates is controlled by a negative regulatory element.
Gaur NA; Manoharlal R; Saini P; Prasad T; Mukhopadhyay G; Hoefer M; Morschhäuser J; Prasad R
Biochem Biophys Res Commun; 2005 Jun; 332(1):206-14. PubMed ID: 15896319
[TBL] [Abstract][Full Text] [Related]
12. STB5 is a negative regulator of azole resistance in Candida glabrata.
Noble JA; Tsai HF; Suffis SD; Su Q; Myers TG; Bennett JE
Antimicrob Agents Chemother; 2013 Feb; 57(2):959-67. PubMed ID: 23229483
[TBL] [Abstract][Full Text] [Related]
13. Increased expression and hotspot mutations of the multidrug efflux transporter, CDR1 in azole-resistant Candida albicans isolates from vaginitis patients.
Looi CY; D' Silva EC; Seow HF; Rosli R; Ng KP; Chong PP
FEMS Microbiol Lett; 2005 Aug; 249(2):283-9. PubMed ID: 16006060
[TBL] [Abstract][Full Text] [Related]
14. Azole Resistance Reduces Susceptibility to the Tetrazole Antifungal VT-1161.
Monk BC; Keniya MV; Sabherwal M; Wilson RK; Graham DO; Hassan HF; Chen D; Tyndall JDA
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397057
[TBL] [Abstract][Full Text] [Related]
15. Flucytosine antagonism of azole activity versus Candida glabrata: role of transcription factor Pdr1 and multidrug transporter Cdr1.
Steier Z; Vermitsky JP; Toner G; Gygax SE; Edlind T; Katiyar S
Antimicrob Agents Chemother; 2013 Nov; 57(11):5543-7. PubMed ID: 23979762
[TBL] [Abstract][Full Text] [Related]
16. Unexpected effects of azole transporter inhibitors on antifungal susceptibility in Candida glabrata and other pathogenic Candida species.
Nagayoshi Y; Miyazaki T; Shimamura S; Nakayama H; Minematsu A; Yamauchi S; Takazono T; Nakamura S; Yanagihara K; Kohno S; Mukae H; Izumikawa K
PLoS One; 2017; 12(7):e0180990. PubMed ID: 28700656
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
Sanguinetti M; Posteraro B; Fiori B; Ranno S; Torelli R; Fadda G
Antimicrob Agents Chemother; 2005 Feb; 49(2):668-79. PubMed ID: 15673750
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms associated with Fluconazole resistance in clinical Candida albicans isolates from India.
Mane A; Vidhate P; Kusro C; Waman V; Saxena V; Kulkarni-Kale U; Risbud A
Mycoses; 2016 Feb; 59(2):93-100. PubMed ID: 26648048
[TBL] [Abstract][Full Text] [Related]
19. Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.
Niimi M; Niimi K; Tanabe K; Cannon RD; Lamping E
Antimicrob Agents Chemother; 2022 Jan; 66(1):e0174821. PubMed ID: 34780272
[TBL] [Abstract][Full Text] [Related]
20. Unmasking of CgYor1-Dependent Azole Resistance Mediated by Target of Rapamycin (TOR) and Calcineurin Signaling in Candida glabrata.
Kumari S; Kumar M; Esquivel BD; Wasi M; Pandey AK; Kumar Khandelwal N; Mondal AK; White TC; Prasad R; Gaur NA
mBio; 2022 Feb; 13(1):e0354521. PubMed ID: 35038899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
